SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007479
Filing Date
2024-05-09
Accepted
2024-05-09 09:00:45
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20240331x10q.htm   iXBRL 10-Q 921425
2 EX-3.1 nrbo-20240331xex3d1.htm EX-3.1 177315
3 EX-10.1 nrbo-20240331xex10d1.htm EX-10.1 104253
4 EX-31.1 nrbo-20240331xex31d1.htm EX-31.1 38435
5 EX-31.2 nrbo-20240331xex31d2.htm EX-31.2 38429
6 EX-32.1 nrbo-20240331xex32d1.htm EX-32.1 8340
7 EX-32.2 nrbo-20240331xex32d2.htm EX-32.2 8548
8 GRAPHIC nrbo-20240331x10q001.jpg GRAPHIC 10438
  Complete submission text file 0001558370-24-007479.txt   4869632

Data Files

Seq Description Document Type Size
9 EX-101.SCH nrbo-20240331.xsd EX-101.SCH 29843
10 EX-101.CAL nrbo-20240331_cal.xml EX-101.CAL 31134
11 EX-101.DEF nrbo-20240331_def.xml EX-101.DEF 116788
12 EX-101.LAB nrbo-20240331_lab.xml EX-101.LAB 271320
13 EX-101.PRE nrbo-20240331_pre.xml EX-101.PRE 210151
67 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20240331x10q_htm.xml XML 788859
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 24928853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)